MedTrace Logo

Study to Investigate Blood Samples Drawn With the HemoIV System

NCT06415058 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2025-06-12

No results posted yet for this study

Summary

The goal of this study is to compare blood drawn using a device called HemoIV to standard-of-care blood drawn from a vein in the arm or from an IV catheter. The HemoIV is a device that is attached to an IV line. This device allows for blood to be drawn while a patient is receiving IV fluids.

The main questions it aims to answer are:

* Will the HemoIV device allow blood to be drawn without having to stop IV fluids?
* Will the HemoIV device provide the same laboratory results as blood draws done by current standard practice?

Participants will:

* Receive standard medical procedures and/or treatment;
* Have a HemoIV device inserted into their IV line in one arm;
* Have an blood drawn twice from the HemoIV and from an IV line or needle stick from a vein in the other arm. The second blood draw will be done about 8-22 hours after the first blood draw;
* Have the device removed after the second blood draw;
* Receive a phone call about 8 days later to see how you are doing.

Conditions

  • Measurement of Blood Parameter Equivalency

Interventions

DEVICE

HemoIV

A sterile, single use device. It is a non-patient stick blood collection device that attaches to a peripheral IV catheter (PIV catheter) and allows for blood sample collection to occur during continuous IV infusion therapy. The control blood sampling will occur via standard of care blood draws either through peripheral IV catheter or standard venipuncture.

Sponsors & Collaborators

  • MedTG LLC

    collaborator UNKNOWN

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Sean Collins, MD, MSCi · Vanderbilt University Medical Center

  • Brian Bales, MD · Vanderbilt University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-02
Primary Completion
2025-02-18
Completion
2025-02-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06415058 on ClinicalTrials.gov